Sensory-Evoked Cortical Gamma Oscillation
NCT: NCT05206305 · ACTIVE_NOT_RECRUITING
Brief Summary
The purpose of the study is to investigate the efficacy of cortical gamma oscillation on visual sensory processing and cognitive function in Alzheimer's Disease (AD) patients by combining a therapeutic sensory stimulation device capable of evoking 40-Hz gamma oscillation via non-invasive visual and auditory stimulation with pre-established markers of cortical network activity, i.e., electroencephalography (EEG) and event-related potentials (ERP), to evaluate the applicability of the 40-Hz multimodel sensory stimulation as a novel therapeutic approach for treatment of AD patients.
Frequently Asked Questions
What is Sensory-Evoked Cortical Gamma Oscillation?
Sensory-Evoked Cortical Gamma Oscillation is a clinical trial registered under NCT05206305. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05206305?
The current status of NCT05206305 (Sensory-Evoked Cortical Gamma Oscillation) is: ACTIVE_NOT_RECRUITING.
When did Sensory-Evoked Cortical Gamma Oscillation start?
Sensory-Evoked Cortical Gamma Oscillation started on 2022-07-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.